Survival Benefit With Proapoptotic Molecular and Pathologic Responses From Dual Targeting of Mammalian Target of Rapamycin and Epidermal Growth Factor Receptor in a Preclinical Model of Pancreatic Neuroendocrine Carcinogenesis

Documenti analoghi

• Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis
  di: Nozawa, Hiroaki, et al.
  Pubblicazione: (2006)
• The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors
  di: Phan, Alexandria T., et al.
  Pubblicazione: (2016)
• Determination of Mammalian Target of Rapamycin Hyperactivation as Prognostic Factor in Well-Differentiated Neuroendocrine Tumors
  di: Lamberti, G., et al.
  Pubblicazione: (2017)
• Targeted Inhibition of the Epidermal Growth Factor Receptor and Mammalian Target of Rapamycin Signaling Pathways in Olmsted Syndrome
  di: Zhang, April, et al.
  Pubblicazione: (2020)
• The complexes of mammalian target of rapamycin
  di: Zhou, Hongyu, et al.
  Pubblicazione: (2010)